| 送交者: xiaobeng[★★声望品衔10★★] 于 2022-08-31 6:04 已读 2463 次 | xiaobeng的个人频道 |
转发新闻。 6park.com请回帖里乱骂骗子的那个回帖的家伙不要发神经病。 6park.com 不要在公众场合见到陌生人就开骂骗子。 6park.com就算你花钱去雇佣一个经济专家帮你炒股， 也不能保证你就赚💰。 6park.com我家不发行任何股票，你赔钱对我没半点好坏处。你嘴贱倒是可以成为公开的免费乐趣。 没欠你啥， 爱看不看。你就是破产了也没我任何坏处。😄 6park.comPrint Article 6park.com6park.comSource: 6park.com Osteopore已与中国的Kontour Xi'an签订了发行版协议，颅骨手术产品将成为首批销售的产品
Kontour将支付Osteopore在中国监管机构全面注册的所有许可和合规费用
这份为期四年的合同
6park.com
6park.comASX-listed Osteopore (ASX:OSX) has this week revealed its entrance into the Chinese market with distributor Kontour (Xi’an) agreeing to purchase $0.72m of Osteopore’s products in the next twelve months for sale into the Chinese market.
In the second year of the agreement, Kontour will purchase $1.45m of Osteopore product, assuming healthy demand through the first year from Chinese consumers.
Ahead of that second year revenue, Kontour and Osteopore will complete a number of trials to achieve approvals from Chinese government healthcare market regulator National Medical Products Association (NMPA).
Kontour is listed on the Shanghai Stock Exchange and boasts a market value of $711m. 6park.com
贴主:xiaobeng于2022_08_31 7:48:04编辑
贴主:xiaobeng于2022_08_31 7:56:22编辑
请点这里投票，“赞”助支持！